id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-D-0591-0001,FDA,FDA-2009-D-0591,Guidance to Pharmacies on Advance Compounding of Tamiflu Oral Suspension to Provide for Multiple Prescriptions;Availability,Notice,NAD-Notice of Availability of Data,2009-12-29T05:00:00Z,2009,12,2009-12-29T05:00:00Z,,2009-12-29T14:32:34Z,E9-30750,0,0,0900006480a7313d
FDA-2009-D-0591-0002,FDA,FDA-2009-D-0591,Guidance to Pharmacies on Advance Compounding of Tamiflu Oral Suspension to Provide for Multiple Prescriptions,Other,GDL-Guidance (Supporting and Related Materials),2009-12-29T05:00:00Z,2009,12,2009-12-29T05:00:00Z,,2024-11-07T22:11:11Z,,1,0,0900006480a73756